Vita 34 AG - ESG Rating & Company Profile powered by AI
The report of Vita 34 AG employs data points from across the web as well as from public disclosures by Vita 34 AG. If you work at Vita 34 AG and you wish to licence your ESG aseessment, please contact us. The analysis of Vita 34 AG is assembled by All Street Sevva using leading artificial intelligence.
Vita 34 AG in the Biotechnology & Medical Research industry gained a UN SDG ESG Transparency Score of 6.3; made up of an environmental score of 8.0, social score of 4.8 and governance score of 6.0.
6.3
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Analytik Jena AG | 8.0 | High |
1 | Amniotics AB (publ) | 8.0 | High |
34 | Tali Digital Ltd | 6.7 | High |
34 | Theradiag SA | 6.7 | High |
40 | Vita 34 AG | 6.3 | High |
40 | Genentech Inc | 6.3 | High |
40 | ZS Pharma Inc | 6.3 | High |
... | ... | ... | |
182 | Wesana Health Holdings Inc | 0.0 | Low |
182 | rEVO Biologics Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Vita 34 AG have an accelerator or VC vehicle to help deliver innovation?
Does Vita 34 AG disclose current and historical energy intensity?
Does Vita 34 AG report the average age of the workforce?
Does Vita 34 AG reference operational or capital allocation in relation to climate change?
Does Vita 34 AG disclose its ethnicity pay gap?
Does Vita 34 AG disclose cybersecurity risks?
Does Vita 34 AG offer flexible work?
Does Vita 34 AG have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Vita 34 AG disclose the number of employees in R&D functions?
Does Vita 34 AG conduct supply chain audits?
Does Vita 34 AG disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Vita 34 AG conduct 360 degree staff reviews?
Does Vita 34 AG disclose the individual responsible for D&I?
Does Vita 34 AG disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Vita 34 AG disclose current and / or historical scope 2 emissions?
Does Vita 34 AG disclose water use targets?
Does Vita 34 AG have careers partnerships with academic institutions?
Did Vita 34 AG have a product recall in the last two years?
Does Vita 34 AG disclose incidents of discrimination?
Does Vita 34 AG allow for Work Councils/Collective Agreements to be formed?
Has Vita 34 AG issued a profit warning in the past 24 months?
Does Vita 34 AG disclose parental leave metrics?
Does Vita 34 AG disclose climate scenario or pathway analysis?
Does Vita 34 AG disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Vita 34 AG disclose the pay ratio of women to men?
Does Vita 34 AG support suppliers with sustainability related research and development?
Does Vita 34 AG disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Vita 34 AG reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Vita 34 AG involved in embryonic stem cell research?
Does Vita 34 AG disclose GHG and Air Emissions intensity?
Does Vita 34 AG disclose its waste policy?
Does Vita 34 AG report according to TCFD requirements?
Does Vita 34 AG disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Vita 34 AG disclose energy use targets?
Does Vita 34 AG disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Vita 34 AG have a policy relating to cyber security?
Have a different question?
Potential Risks for Vita 34 AG
These potential risks are based on the size, segment and geographies of the company.
VITA 34 AG engages in the collection, processing, and storage of stem cells from umbilical cord blood and tissue in Germany, Spain, and internationally. It also develops cell therapeutic procedures; cell and gene therapies; cryopreservation of endogenous immune cells; and CAR-T. In addition, the company manufactures advanced therapy medicinal products based on mesenchymal stem cells for experimental treatment by specialized medical institutions; preserves stem cells from perinatal tissue and adult body fat; and engages in the contract manufacturing of pharmaceutical intermediates. VITA 34 AG was founded in 1997 and is based in Leipzig, Germany.